Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study

SIMPLE SUMMARY: Gemcitabine/nab-paclitaxel (GN) and FOLFIRINOX (FFX) are two standard first-line therapies for metastatic pancreatic cancer (PC) but have rarely been compared, especially in patients with locally advanced PC (LAPC). By carefully selecting patients, it is likely these two regimens lea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Williet, Nicolas, Petrillo, Angelica, Roth, Gaël, Ghidini, Michele, Petrova, Mila, Forestier, Julien, Lopez, Anthony, Thoor, Audrey, Weislinger, Lucie, De Vita, Ferdinando, Taieb, Julien, Phelip, Jean Marc
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8200096/
https://ncbi.nlm.nih.gov/pubmed/34199796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13112797
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars